RECRUITING

Comprehensive HIV and Harm Prevention Via Telehealth

Conditions

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to test 2 different ways to offer medications to prevent human immunodeficiency virus (HIV), cure hepatitis C virus (HCV) (if applicable) and treat substance use disorder (if desired) in people who inject drugs.

Official Title

Comprehensive HIV and Harm Prevention Via Telehealth: CHARIOT, a Randomized Controlled Trial

Quick Facts

Study Start:2024-10-07

Study Completion:2027-10-09

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:RECRUITING

Study ID

NCT05897099

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:No

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
* age 18 or older * able to speak English or Spanish * willing and able to sign informed consent, provide locator information and medical records release * non-reactive result on rapid HIV test * use of SSP to exchange syringes 2 times in the past 3 months * planning to stay in the area for 12 months	* reactive HIV test * currently on medications for opioid use disorder (MOUD) by urine drug screen * currently on PrEP by self-report * Principal or site investigator discretion * currently in prison or jail * current enrollment in Clinical Trials Network 121 * receipt of tele-harm reduction in previous 3 months * signs or symptoms of acute HIV infection

Contacts and Locations

Study Contact

Hansel Tookes, MD

CONTACT

3052431615

hetookes@med.miami.edu

Principal Investigator

Hansel Tookes, MD

PRINCIPAL_INVESTIGATOR

University of Miami

Tyler Bartholomew, PhD

PRINCIPAL_INVESTIGATOR

University of Miami

Study Locations (Sites)

IDEA Miami

Miami, Florida, 33136

United States

IDEA Syringe Services Program

Miami, Florida, 33136

United States

Collaborators and Investigators

Sponsor: University of Miami

Hansel Tookes, MD, PRINCIPAL_INVESTIGATOR, University of Miami
Tyler Bartholomew, PhD, PRINCIPAL_INVESTIGATOR, University of Miami

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-10-07

Study Completion Date2027-10-09

Study Record Updates

Study Start Date2024-10-07

Study Completion Date2027-10-09

Terms related to this study

Additional Relevant MeSH Terms

HIV Infections